Telix Pharmaceuticals Limited (TLX.AX)
AUD 28.32
(12.47%)
AUD 28.32
(12.47%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 398.3 Million AUD | 52.85% |
| 2022 | 260.59 Million AUD | 137.3% |
| 2021 | 109.81 Million AUD | -33.22% |
| 2020 | 164.44 Million AUD | 60.26% |
| 2019 | 102.6 Million AUD | 33.76% |
| 2018 | 76.7 Million AUD | 50.13% |
| 2017 | 51.09 Million AUD | 0.0% |
| 2000 | 9.39 Million AUD | 0.0% |
| 1999 | - AUD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 745.95 Million AUD | 0.0% |
| 2023 Q2 | 310.33 Million AUD | 0.0% |
| 2023 Q4 | 398.3 Million AUD | 0.0% |
| 2023 FY | 398.3 Million AUD | 52.85% |
| 2022 Q4 | 260.59 Million AUD | 0.0% |
| 2022 FY | 260.59 Million AUD | 137.3% |
| 2022 Q2 | 215.94 Million AUD | 0.0% |
| 2021 FY | 109.81 Million AUD | -33.22% |
| 2021 Q4 | 109.81 Million AUD | 0.0% |
| 2021 Q2 | 128.84 Million AUD | 0.0% |
| 2020 FY | 164.44 Million AUD | 60.26% |
| 2020 Q4 | 164.44 Million AUD | 0.0% |
| 2020 Q2 | 99.01 Million AUD | 0.0% |
| 2019 Q2 | 65.49 Million AUD | 0.0% |
| 2019 Q4 | 102.6 Million AUD | 0.0% |
| 2019 FY | 102.6 Million AUD | 33.76% |
| 2018 Q4 | 76.7 Million AUD | 0.0% |
| 2018 FY | 76.7 Million AUD | 50.13% |
| 2018 Q2 | 48.51 Million AUD | 0.0% |
| 2017 Q4 | 51.09 Million AUD | 0.0% |
| 2017 Q2 | 6.92 Million AUD | 0.0% |
| 2017 FY | 51.09 Million AUD | 0.0% |
| 2000 FY | 9.39 Million AUD | 0.0% |
| 1999 FY | - AUD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Acrux Limited | 8.96 Million AUD | -4343.847% |
| Chimeric Therapeutics Limited | 15.27 Million AUD | -2507.857% |
| Clarity Pharmaceuticals Ltd | 154.62 Million AUD | -157.585% |
| Clinuvel Pharmaceuticals Limited | 231.12 Million AUD | -72.333% |
| Neuren Pharmaceuticals Limited | 247.97 Million AUD | -60.625% |
| Radiopharm Theranostics Limited | 72.03 Million AUD | -452.918% |
| AdAlta Limited | 5.57 Million AUD | -7046.993% |
| Alterity Therapeutics Limited | 19.22 Million AUD | -1971.927% |
| Botanix Pharmaceuticals Limited | 112.46 Million AUD | -254.158% |
| BTC Health Limited | 5.14 Million AUD | -7635.811% |
| CSL Limited | 56.93 Billion AUD | 99.3% |
| EZZ Life Science Holdings Limited | 25.55 Million AUD | -1458.791% |
| Hexima Limited | 2.26 Million AUD | -17454.046% |
| Immutep Limited | 147.44 Million AUD | -170.129% |
| Memphasys Limited | 12.43 Million AUD | -3104.323% |
| Noxopharm Limited | 6.78 Million AUD | -5771.406% |
| Prescient Therapeutics Limited | 20.39 Million AUD | -1853.145% |
| Race Oncology Limited | 20.22 Million AUD | -1869.007% |
| Starpharma Holdings Limited | 36.81 Million AUD | -981.931% |
| Tissue Repair Ltd | 19.38 Million AUD | -1954.207% |
| Biotron Limited | 493.47 Thousand AUD | -80613.55% |
| Biome Australia Limited | 8.27 Million AUD | -4712.276% |
| Anatara Lifesciences Ltd | 1.67 Million AUD | -23730.128% |
| Bio-Gene Technology Limited | 3.15 Million AUD | -12506.129% |
| Zelira Therapeutics Limited | 5.18 Million AUD | -7584.159% |
| Patrys Limited | 4.16 Million AUD | -9470.932% |
| Orthocell Limited | 26.61 Million AUD | -1396.52% |
| Imugene Limited | 151.39 Million AUD | -163.083% |
| PYC Therapeutics Limited | 91.23 Million AUD | -336.549% |
| Proteomics International Laboratories Limited | 10.87 Million AUD | -3562.509% |
| Cynata Therapeutics Limited | 8.38 Million AUD | -4648.31% |
| Arovella Therapeutics Limited | 13.28 Million AUD | -2898.205% |
| Nanollose Limited | 241.95 Thousand AUD | -164520.936% |
| Invex Therapeutics Ltd | 6.12 Million AUD | -6408.148% |
| NeuroScientific Biopharmaceuticals Limited | 5.43 Million AUD | -7227.287% |
| Amplia Therapeutics Limited | 14.84 Million AUD | -2583.052% |
| Island Pharmaceuticals Limited | 2.56 Million AUD | -15431.546% |
| Nyrada Inc. | 5.9 Million AUD | -6642.581% |
| Dimerix Limited | 32.07 Million AUD | -1141.646% |
| PharmAust Limited | 11.12 Million AUD | -3480.291% |
| AnteoTech Limited | 9.38 Million AUD | -4145.756% |
| Paradigm Biopharmaceuticals Limited | 27.39 Million AUD | -1354.164% |
| Recce Pharmaceuticals Ltd | 6.36 Million AUD | -6153.158% |
| Avecho Biotechnology Limited | 7.31 Million AUD | -5341.797% |
| Actinogen Medical Limited | 21.31 Million AUD | -1768.921% |
| Immuron Limited | 15.54 Million AUD | -2461.433% |
| Argenica Therapeutics Limited | 16.37 Million AUD | -2331.999% |